Multiple-dose pharmacokinetics of peginterferon alfa-2b in patients with renal insufficiencyGUPTA, Samir K; SWAN, Suzanne K; MARBURY, Thomas et al.British journal of clinical pharmacology. 2007, Vol 64, Num 6, pp 726-732, issn 0306-5251, 7 p.Article

Adjuvant interferon alfa in malignant melanoma: An interdisciplinary and multinational expert reviewASCIERTO, Paolo A; GOGAS, Helen J; JACQUES GROB, Jean et al.Critical reviews in oncology/hematology. 2013, Vol 85, Num 2, pp 149-161, issn 1040-8428, 13 p.Article

Peginterferon alfa-2b and ribavirin for 12 vs. 24 weeks in HCV genotype 2 or 3MANGIA, Alessandra; SANTORO, Rosanna; ROMANO, Mario et al.The New England journal of medicine. 2005, Vol 352, Num 25, pp 2609-2617, issn 0028-4793, 9 p.Article

Randomized Trial of Peginterferon alfa-2b and Ribavirin for 48 or 72 Weeks in Patients with Hepatitis C Virus Genotype 1 and Slow Virologic ResponseBUTI, Maria; LURIE, Yoav; PEDICONE, Lisa D et al.Hepatology (Baltimore, Md.). 2010, Vol 52, Num 4, pp 1201-1207, issn 0270-9139, 7 p.Article

Multiplex analysis of Serum cytokines in melanoma patients treated with interferon-α2bYURKOVETSKY, Zoya R; KIRKWOOD, John M; EDINGTON, Howard D et al.Clinical cancer research. 2007, Vol 13, Num 8, pp 2422-2428, issn 1078-0432, 7 p.Article

Biochip as a potential platform of serological interferon α2b antibody assayWEIDONG DU; ZHENSHAN XU; XUELING MA et al.Journal of biotechnology. 2003, Vol 106, Num 1, pp 87-100, issn 0168-1656, 14 p.Article

Interferon alpha-2b as adjuvant treatment of recurrent respiratory papillomatosis in Cuba: National Programme (1994-1999 report)NODARSE-CUNI, Hugo; IZNAGA-MARIN, Nora; VIERA-ALVAREZ, Ditza et al.Journal of laryngology and otology. 2004, Vol 118, Num 9, pp 681-687, issn 0022-2151, 7 p.Article

Synthesis and biological properties of chimeric interferon-α2b peptidesPENA, Clara; BLANK, Viviana C; MARINO, Veronica J et al.Peptides (New York, NY. 1980). 2005, Vol 26, Num 7, pp 1144-1149, issn 0196-9781, 6 p.Article

Toxicity and exposure of an adenovirus containing human interferon alpha-2b following intracystic administration in cynomolgus monkeysVENEZIALE, R. W; KISHNANI, N. S; HUBBELL, J et al.Gene therapy (Basingstoke). 2012, Vol 19, Num 7, pp 742-751, issn 0969-7128, 10 p.Article

Expression of Biologically Active Human Recombinant Interferon Alpha 2b in Human Breast Cancer Cell Line Bcap-37HUI LI; XIANGPING LI; QINGYOU LIU et al.Applied biochemistry and biotechnology. 2013, Vol 171, Num 6, pp 1535-1544, issn 0273-2289, 10 p.Article

Treatment of conjunctival squamous neoplasias with interferon alpha 2bHUERVA, V; MANGUES, I.Journal français d'ophtalmologie. 2008, Vol 31, Num 3, pp 317-325, issn 0181-5512, 9 p.Article

Interferon alpha for the adjuvant treatment of melanoma: review of international literature and practical recommendations from an expert panel on the use of interferonASCIERTO, Paolo A; CHIARION-SILENI, Vanna; MUGGIANO, Antonio et al.Journal of chemotherapy (Testo stampato). 2014, Vol 26, Num 4, pp 193-201, issn 1120-009X, 9 p.Article

Expression of biologically active human interferon alpha 2b in the milk of transgenic miceHUI LI; QINGYOU LIU; KUIQING CUI et al.Transgenic research. 2013, Vol 22, Num 1, pp 169-178, issn 0962-8819, 10 p.Article

IL-22 : A critical mediator in mucosal host defenseAUJLA, S. J; KOLLS, J. K.Journal of molecular medicine (Berlin. Print). 2009, Vol 87, Num 5, pp 451-454, issn 0946-2716, 4 p.Article

Clinical trial : pharmacodynamics and pharmacokinetics of re-treatment with fixed-dose induction of peginterferon α-2a in hepatitis C virus genotype 1 true non-responder patientsOTAGO, M; CRESPO, J; OLVEIRA, A et al.Alimentary pharmacology & therapeutics. 2007, Vol 26, Num 8, pp 1131-1138, issn 0269-2813, 8 p.Article

Pharmacodynamics of peginterferon alfa-2a and peginterferon alfa-2b in interferon-natve patients with chronic hepatitis C : a randomized, controlled studyBRUNO, R; SACCHI, P; SCAGNOLARI, C et al.Alimentary pharmacology & therapeutics. 2007, Vol 26, Num 3, pp 369-376, issn 0269-2813, 8 p.Article

Prediction of Sustained Response to Peginterferon Alfa-2b for Hepatitis B e Antigen-Positive Chronic Hepatitis B Using On-Treatment Hepatitis B Surface Antigen DeclineSONNEVELD, Milan J; RIJCKBORST, Vincent; BOUCHER, Charles A. B et al.Hepatology (Baltimore, Md.). 2010, Vol 52, Num 4, pp 1251-1257, issn 0270-9139, 7 p.Article

Successful treatment with peginterferon alfa-2b of HBeAg-positive HBV non-responders to standard interferon or lamivudineFLINK, Hajo J; HANSEN, Bettina E; SCHALM, Solko W et al.The American journal of gastroenterology. 2006, Vol 101, Num 11, pp 2523-2529, issn 0002-9270, 7 p.Article

Peginterferon alfa-2b and ribavirin for treatment-refractory chronic hepatitis CKRAWITT, Edward L; ASHIKAGA, Takamam; GORDON, Stuart R et al.Journal of hepatology. 2005, Vol 43, Num 2, pp 243-249, issn 0168-8278, 7 p.Article

Adherence to assigned dosing regimen and sustained virological response among chronic hepatitis C genotype 1 patients treated with boceprevir plus peginterferon alfa-2b/ribavirinGORDON, S. C; YOSHIDA, E. M; BURROUGHS, M. H et al.Alimentary pharmacology & therapeutics. 2013, Vol 38, Num 1, pp 16-27, issn 0269-2813, 12 p.Article

Peginterféron alpha-2b pour traiter le mélanome = Peginterferon Alfa-2b (Sylatron) for MelanomaThe Medical letter on drugs and therapeutics (Edition française). 2011, Vol 33, Num 21, issn 0253-8512, p. 84Article

Response to Peginterferon-alfa 2b and Ribavirin in Japanese Patients with Chronic Hepatitis C Genotype 2KANDA, Tatsuo; IMAZEKI, Fumio; TAWADA, Akinobu et al.Digestive diseases and sciences. 2011, Vol 56, Num 11, pp 3335-3342, issn 0163-2116, 8 p.Article

Durability of Peginterferon alfa-2b Treatment at 5 Years in Patients with Hepatitis B e Antigen-Positive Chronic Hepatitis BWONG, Vincent Wai-Sun; WONG, Grace Lai-Hung; YAN, Kenneth Kar-Lung et al.Hepatology (Baltimore, Md.). 2010, Vol 51, Num 6, pp 1945-1953, issn 0270-9139, 9 p.Article

Complete clinical and virological remission of refractory HIV-related Kaposi's sarcoma with pegylated interferon alphaVAN DER ENDE, Marchina; MULDER, Jan Willem; VAN DEN BERGE, Marcel et al.AIDS (London). 2007, Vol 21, Num 12, pp 1661-1662, issn 0269-9370, 2 p.Article

Peginterferon-α-2a (40 kD): A Review of its Use in Chronic Hepatitis BKEATING, Gillian M.Drugs (Basel). 2009, Vol 69, Num 18, pp 2633-2660, issn 0012-6667, 28 p.Article